These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7685943)

  • 1. Allosteric modulations of the nicotinic acetylcholine receptor.
    Léna C; Changeux JP
    Trends Neurosci; 1993 May; 16(5):181-6. PubMed ID: 7685943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the structure of the uncoupled nicotinic acetylcholine receptor.
    Sun J; Comeau JF; Baenziger JE
    Biochim Biophys Acta Biomembr; 2017 Feb; 1859(2):146-154. PubMed ID: 27871840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixation of allosteric states of the nicotinic acetylcholine receptor by chemical cross-linking.
    Watty A; Methfessel C; Hucho F
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8202-7. PubMed ID: 9223339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kinetic mechanism for nicotinic acetylcholine receptors based on multiple allosteric transitions.
    Edelstein SJ; Schaad O; Henry E; Bertrand D; Changeux JP
    Biol Cybern; 1996 Nov; 75(5):361-79. PubMed ID: 8983160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200.
    Mallipeddi PL; Pedersen SE; Briggs JM
    J Mol Graph Model; 2013 Jul; 44():145-54. PubMed ID: 23831994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding properties of agonists and antagonists to distinct allosteric states of the nicotinic acetylcholine receptor are incompatible with a concerted model.
    Krauss M; Korr D; Herrmann A; Hucho F
    J Biol Chem; 2000 Sep; 275(39):30196-201. PubMed ID: 10900197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nicotinic acetylcholine receptor and its prokaryotic homologues: Structure, conformational transitions & allosteric modulation.
    Cecchini M; Changeux JP
    Neuropharmacology; 2015 Sep; 96(Pt B):137-49. PubMed ID: 25529272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multiple phenotypes of allosteric receptor mutants.
    Galzi JL; Edelstein SJ; Changeux J
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1853-8. PubMed ID: 8700848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physostigmine and neuromuscular transmission.
    Maelicke A; Coban T; Schrattenholz A; Schröder B; Reinhardt-Maelicke S; Storch A; Godovac-Zimmermann J; Methfessel C; Pereira EF; Albuquerque EX
    Ann N Y Acad Sci; 1993 Jun; 681():140-54. PubMed ID: 8395146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
    Dodson BA; Braswell LM; Miller KW
    Mol Pharmacol; 1987 Jul; 32(1):119-26. PubMed ID: 3600612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of a novel channel-activating site on nicotinic acetylcholine receptors.
    Schrattenholz A; Coban T; Schröder B; Okonjo KO; Kuhlmann J; Pereira EF; Albuquerque EX; Maelicke A
    J Recept Res; 1993; 13(1-4):393-412. PubMed ID: 7680720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acetylcholine receptor labeled with a tritiated, photoactivatable agonist: a new tool for investigating the functional, activated state.
    Kotzyba-Hibert F; Kessler P; Zerbib V; Grutter T; Bogen C; Takeda K; Hammadi A; Knerr L; Goeldner M
    Bioconjug Chem; 1997; 8(4):472-80. PubMed ID: 9258443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nicotinic acetylcholine receptor of the Torpedo electric ray.
    Unwin N
    J Struct Biol; 1998; 121(2):181-90. PubMed ID: 9615437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor.
    Spurny R; Debaveye S; Farinha A; Veys K; Vos AM; Gossas T; Atack J; Bertrand S; Bertrand D; Danielson UH; Tresadern G; Ulens C
    Proc Natl Acad Sci U S A; 2015 May; 112(19):E2543-52. PubMed ID: 25918415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic agonist and antagonist interactions on the putative nicotinic cholinoceptor of motor neurons.
    Bierkamper GG; Aizenman E
    Proc West Pharmacol Soc; 1984; 27():353-6. PubMed ID: 6494174
    [No Abstract]   [Full Text] [Related]  

  • 17. Nicotinic receptors, allosteric proteins and medicine.
    Changeux JP; Taly A
    Trends Mol Med; 2008 Mar; 14(3):93-102. PubMed ID: 18262468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lipid-dependent uncoupled conformation of the acetylcholine receptor.
    daCosta CJ; Baenziger JE
    J Biol Chem; 2009 Jun; 284(26):17819-25. PubMed ID: 19357079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel.
    Kuhlmann J; Okonjo KO; Maelicke A
    FEBS Lett; 1991 Feb; 279(2):216-8. PubMed ID: 1705896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative modulation of nicotinic receptors.
    Arias HR
    Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.